Literature DB >> 6171682

Effects of niludipine (Bay-a-7168) on transmembrane action potentials of rabbit sinus node cells and atrial muscle fibers.

I Kodama, Y Hirata, J Toyama, K Yamada.   

Abstract

Effects of niludipine (bis(2-propoxyethyl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedic arboxylate; Bay-a-7168) on isolated rabbit sinus node and right atrial preparations were studied using intracellular microelectrode techniques. Niludipine in concentrations above 1 X 10(-8) M caused dose-dependent changes in the membrane action potentials of the preparations. In spontaneously firing sinus node cells, a marked decrease in the amplitude (AMP) and maximum rate of depolarization (MRD) of action potentials as well as a slight decrease in their maximum diastolic potential (MDP) were observed after drug administration. In constantly driven atrial muscle fibers, the early repolarizing phase was accelerated (shortening of action potential duration) and AMP was decreased by several millivolts. However, little change occurred in the MDP and MRD of atrial muscle fibers even at the highest concentration (1 X 10(-6) M). Niludipine prolonged the effective refractory period of atrial muscle fibers by 4--8 msec. At the same time, it caused a marked decrease in the amplitude of the premature action potentials and prolonged their propagation time. Most of these effects of niludipine, which may be attributed to the reduction of the slow inward current through the myocardial cell membrane, were antagonized by the concomitant administration of isoproterenol (1 X 10(-6) M).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6171682     DOI: 10.1097/00005344-198003000-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  1 in total

1.  Suppression by orally-administered nifedipine, nisoldipine and niludipine of early, life-threatening ventricular arrhythmias resulting from acute myocardial ischaemia.

Authors:  O Fagbemi; J R Parratt
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.